(Q60230370)

English

NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application

article by Robert Trondl et al published 4 April 2014 in Chemical Science

Statements

NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application (English)
0 references
0 references
0 references
Robert Trondl
0 references
Christian R. Kowol
0 references
Walter Berger
0 references
Bernhard K. Keppler
0 references
4 April 2014
0 references
5
0 references
8
0 references
2925-2932
0 references

Identifiers

0 references
 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit